Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 184 HER2-positive Breast Cancer 18 Neoplasms 13 Neoplasm Metastasis 11 Prostatic Neoplasms 7 Ovarian Neoplasms 7 Stomach Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Pancreatic Neoplasms 5 Inflammatory Breast Neoplasms 5 Colonic Neoplasms 5 Brain Neoplasms 5 Triple Negative Breast Neoplasms 4 Multiple Myeloma 4 Hematologic Neoplasms 4 Endometrial Neoplasms 4 Colorectal Neoplasms 4 Urinary Bladder Neoplasms 3 Solid Tumor 3 Rectal Neoplasms 3 Pathologic Complete Response 3 Lymphoma, Non-Hodgkin 3 Lung Neoplasms 3 HER2-positive Early Breast Cancer 3 Esophageal Neoplasms 3 Breast Neoplasms, Male 3 Biliary Tract Neoplasms 3 Anatomic Stage I Breast Cancer AJCC v8 3 Salivary Gland Neoplasms 2 Locally Advanced Breast Cancer 2

Interventions

Blood Specimen Collection 29 Reverse Transcriptase Polymerase Chain Reaction 7 Flow Cytometry 7 Surgical Procedures, Operative 4 Liquid Biopsy 4 cabazitaxel 3 Trastuzumab 3 Propofol 3 Carboplatin 3 Bevacizumab 3 Standard of Care 2 Spinal Puncture 2 Sevoflurane 2 Positron Emission Tomography Computed Tomography 2 Pirinitramide 2 Neoadjuvant Therapy 2 Morphine 2 Laparoscopy 2 Hematologic Tests 2 Gemcitabine 2 Folfox protocol 2 Epirubicin 2 Drug Therapy 2 Docetaxel 2 Cyclophosphamide 2 Cisplatin 2 Cetuximab 2 Capecitabine 2 Aspirin 2 Anesthesia, General 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplastic Cells, Circulating × pertuzumab × Clear all

NCT04993014 2021-08-06

HER2Cell

AC Camargo Cancer Center

Phase 2 Recruiting

Breast Neoplasms, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡